Latest Posts Under: Pharma Industry News

Taro recalls lot of Lamotrigine tablets in US due to contamination

Taro Pharmaceuticals U.S.A. has issued to recall of a lot of Lamotrigine 100 mg tablets owing to cross-contamination with a trace of another drug substance – Enalapril Maleate. Lamotrigine is indicated for the treatment of epilepsy and bipolar disorders. The US pharmaceutical manufacturer is recalling Lot # 331771, which has an expiration date June 2021 […]

PACT Pharma raises $75m to develop neoTCR-T cell therapies for solid tumors

PACT Pharma, a California-based clinical stage company, which is focused on developing fully personalized neoTCR-T cell therapies for solid tumors, has raised $75 million in a Series C financing round. The funding round was led by Vida Ventures, a life science venture firm, with participation from the current investors of PACT Pharma. The clinical stage […]

MiraDx to enroll patients for non-tumor based microRNA clinical trial

MicroRNA clinical trial : MiraDx, a Los Angeles-based molecular genetics company, has initiated patient enrollment in collaboration with UCLA for the non-tumor based microRNA biomarker-driven clinical trial for KRAS-variant positive HPV-positive head and neck cancer patients (HNSCC). The clinical trial will randomly group 70 patients to receive the current standard of care (radiation plus cisplatin) […]

Carmell Therapeutics gets IND clearance for CT-101 bone healing accelerant

Carmell Therapeutics has secured clearance from the US Food and Drug Administration (FDA) for its investigational new drug application (IND) for CT-101, its first product, which is a bone healing accelerant (BHA). The Pennsylvania biotech company is engaged in the development and commercialization of plasma-based bioactive materials (PBMs) to speed up bone and soft tissue […]

ATAI Life Sciences partners with Neuronasal to develop concussion treatment

ATAI Life Sciences, a German biotech company focused on developing drugs for mental illnesses, has partnered with Neuronasal to develop a short-term treatment for mild traumatic brain injury (mTBI) or concussion. Neuronasal’s concussion treatment includes the intranasal delivery of low doses of N-acetylcysteine (NAC) to patients with acute concussion. N-acetylcysteine has been safely used for […]

Chinese pharma company CF PharmTech raises $90m for respiratory drugs

Chinese pharma company CF PharmTech has secured a $90 million Series E investment led by New Alliance Capital for accelerating the global development of respiratory drugs. The investment round saw participation from new investors such as CR-CP Life Science Fund, Finnova Capital, Xiangcheng Financial, GT Capital, Co-stone Asset Management, and Everest Venture Capital. Existing investors […]

Biotricity completes development of Biopatch ECG patch platform

Biotricity said that it has wrapped up development of Biopatch, a new ECG patch platform for cardiac patients with fewer complications. The US medical technology company has developed the new ECG patch platform in a miniaturized form factor having three standard electrodes, with no lead wires. Biotricity is an extension of the company’s Bioflux device, […]

Impulse Dynamics raises $80m to commercialize Optimizer Smart System

Impulse Dynamics, a US medical device company, has secured $80.25 million in a Series D financing round led by medical technology investor Amzak Health Investors for the commercialization of its Optimizer Smart System for heart failure. Optimizer Smart System is an implantable device which has been approved by the US Food and Drug Administration (FDA) […]

Baxter to acquire Seprafilm Adhesion Barrier from Sanofi for $350m

Baxter International, a US-based health care company, has signed a deal worth $350 million to acquire Seprafilm Adhesion Barrier and related assets from French pharma company Sanofi, in a move to expand its advanced surgery portfolio. Seprafilm Adhesion Barrier is a medical device, which has FDA approval for preventing adhesion in patients going through abdominal […]

Scroll To Top